Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 8 articles:
HTML format
Text format



Single Articles


    July 2018
  1. STOWER H
    Searching for Alzheimer's disease therapies.
    Nat Med. 2018;24:894-897.
    PubMed     Text format    


    May 2018
  2. SANCHEZ-MUT JV, Heyn H, Silva BA, Dixsaut L, et al
    PM20D1 is a quantitative trait locus associated with Alzheimer's disease.
    Nat Med. 2018 May 7. pii: 10.1038/s41591-018-0013.
    PubMed     Text format     Abstract available


    April 2018
  3. CHAKRADHAR S
    A tale of two diseases: Aging HIV patients inspire a closer look at Alzheimer's disease.
    Nat Med. 2018;24:376-377.
    PubMed     Text format    


    December 2017
  4. HE Z, Guo JL, McBride JD, Narasimhan S, et al
    Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.
    Nat Med. 2017 Dec 4. pii: nm.4443. doi: 10.1038/nm.4443.
    PubMed     Text format     Abstract available


    September 2017
  5. SALTER MW, Stevens B
    Microglia emerge as central players in brain disease.
    Nat Med. 2017;23:1018-1027.
    PubMed     Text format     Abstract available


    May 2017
  6. LAM AD, Deck G, Goldman A, Eskandar EN, et al
    Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease.
    Nat Med. 2017 May 1. doi: 10.1038/nm.4330.
    PubMed     Text format     Abstract available


    February 2017
  7. WONG YC, Krainc D
    alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies.
    Nat Med. 2017;23:1-13.
    PubMed     Text format     Abstract available


    October 2016
  8. KINCAID E
    Picture imperfect: Going beyond imaging amyloid in Alzheimer's disease.
    Nat Med. 2016;22:1067-1068.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: